Image may be NSFW.
Clik here to view.
Clik here to view.
FDA Approves New Assay for Her2 in Breast Cancer
This week the FDA approved a new assay for Her2 expression in breast cancer biopsies. The technology, Inform Dual ISH, is manufactured by Ventana Medical Systems, a Roche subsidiary. From Ventana...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
FDA Approves Pertuzumab for Advanced, Her2+ Breast Cancer
We’re on a roll for new treatments of the Her2+ form of breast cancer. On Friday the FDA approved Pertuzumab, a monoclonal antibody, for advanced cases. As indicated, the drug would be given along with...
View Article
